In their recent debt to equity, they set a minimum conversion price of 0.002. Which means the company thinks the share price could go there and to 0.001, otherwise why bother setting this floor?
Ann: Halucenex Phase II Clinical Trial Update, page-13
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ME1 (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.125M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| ME1 (ASX) Chart |
Day chart unavailable